Effects of Topical and Subconjunctival Bevacizumab in High-Risk Corneal Transplant Survival

Investigative Ophthalmology and Visual Science - United States
doi 10.1167/iovs.09-3745
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Association for Research in Vision and Ophthalmology (ARVO)

Related search

Comparison of the Effects of Subconjunctival and Topical Anti-Vegf Therapy (Bevacizumab) on Experimental Corneal Neovascularization

Arquivos Brasileiros de Oftalmologia
MedicineOphthalmology
2014English

Corneal and Intraocular Penetration of Topical and Subconjunctival Fusidic Acid.

British Journal of Ophthalmology
Molecular NeuroscienceOphthalmologySensory SystemsCellular
1987English

Topical Bevacizumab in the Treatment of Corneal Neovascularization

Archives of Ophthalmology
2009English

Comparison of the Effects of Subconjunctival Injections of Bevacizumab and Interferon Alpha-2a on Corneal Angiogenesis in a Rat Model

Medicina
Medicine
2018English

Corneal Neovascularization and the Utility of Topical VEGF Inhibition: Ranibizumab (Lucentis) vs Bevacizumab (Avastin)

Ocular Surface
Ophthalmology
2012English

Presurgical Corticosteroid Treatment Improves Corneal Transplant Survival in Mice

Cornea
Ophthalmology
2013English

Bevacizumab-Loaded Polyurethane Subconjunctival Implants: Effects on Experimental Glaucoma Filtration Surgery

Journal of Ocular Pharmacology and Therapeutics
OphthalmologyPharmacology
2013English

Bevacizumab and Corneal Pathology

Medicina fluminensis
2017English

Photodynamic Therapy Leads to Time-Dependent Regression of Pathologic Corneal (Lymph) Angiogenesis and Promotes High-Risk Corneal Allograft Survival

Investigative Ophthalmology and Visual Science
Molecular NeuroscienceOphthalmologySensory SystemsCellular
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy